205 results on '"Kumana, Cyrus R."'
Search Results
2. Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
3. The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases
4. Cardiovascular Disease Prevention: What Makes an Intervention Worthwhile?
5. Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991-2021
6. Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights
7. Effectiveness Of Lipid Lowering Drugs In General Practice
8. Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure
9. Advantages of blood pressure optimization
10. Clinical Role of β-Lactam/β-Lactamase Inhibitor Combinations
11. Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside
12. Oral arsenic trioxide, all‐ trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long‐term results and unique prognostic indicators
13. Raising highly desirable lipoprotein versus lowering deleterious lipoprotein
14. Letter: Viewing JUPITOR with a clear perspective
15. Adrenomedullin gene expression and levels in the cardiovascular system after treatment with lipopolysaccharide
16. Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat
17. Successful Treatment of Relapsed Acute Promyelocytic Leukemia in a Patient Receiving Continuous Ambulatory Peritoneal Dialysis With Oral Arsenic Trioxide
18. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes
19. Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin
20. Effectiveness of lipid lowering drugs in general practice: Study had two major flaws
21. Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections
22. Comparison Of Digoxin Versus Low-Dose Amiodarone For Ventricular Rate Control In Patients With Chronic Atrial Fibrillation
23. β-Lactam Antibiotic and β-Lactamase Inhibitor Combinations
24. Association studies of genetic polymorphisms and complex disease
25. Oral Arsenic Trioxide, ATRA and Ascorbic Acid (AAA) Maintenance Following First Complete Remission in Acute Promyelocytic Leukemia - Long-Term Data and Unique Prognostic Indicators
26. Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study
27. Natriuretic Peptides-Relevance in Cardiovascular Disease
28. Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback"
29. Hospital antibiotic prescribing successfully modified by `immediate concurrent feedback'
30. Oral Arsenic Trioxide in the Frontline Treatment of Newly-Diagnosed Acute Promyelocytic Leukemia: A 5-Year Prospective Cohort Study
31. Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study
32. Effect of new classes of antidiabetic drugs on cardiovascular outcomes in randomised controlled trials: a network meta-analysis
33. Promotion of Oral Anticoagulation in Patients with Atrial Fibrillation: Absolute Impact of Interventions attained in the IMPACT-AF trial
34. Beta-adrenergic blocking drugs
35. Absolute benefits of empagliflozin in type 2 diabetes: a game changer?
36. Dementia and statins
37. [beta]-Lactam Antibiotic and [beta]-Lactamase Inhibitor Combinations
38. Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure
39. Oral arsenic trioxide–based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study
40. Angiotensin Receptor Blockers for Heart Disease: Are They the Same?
41. Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia
42. Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety
43. Screening for Fever by Remote-sensing Infrared Thermographic Camera
44. Arsenic Trioxide in Mantle Cell Lymphoma.
45. Treatment of Relapsed Acute Promyelocytic Leukemia by Arsenic-Based Strategies without Hematopoietic Stem Cell Transplantation in Hong Kong: A Seven-Year Experience.
46. Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia
47. Clinical Role of ??-Lactam/??-Lactamase Inhibitor Combinations
48. Appropriate Use of Clopidogrel
49. Dementia and statins
50. Case of the month
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.